Details for New Drug Application (NDA): 216726
✉ Email this page to a colleague
The generic ingredient in SUCRALFATE is sucralfate. There are fourteen drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the sucralfate profile page.
Summary for 216726
Tradename: | SUCRALFATE |
Applicant: | Abon Pharms Llc |
Ingredient: | sucralfate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 216726
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION;ORAL | Strength | 1GM/10ML | ||||
Approval Date: | Mar 21, 2024 | TE: | AB | RLD: | No |
Complete Access Available with Subscription